Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole
Status:
Recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
This study aims to compare two FDA approved medications (aripiprazole and risperidone) for
the treatment of behavioral dysregulation in children with autism spectrum disorders. This
trial, done in the context of routine clinical care, will seek to evaluate whether
aripiprazole or risperidone is associated with more weight gain in children.